Stay updated on Intratumoral Daromun in Skin Cancer: Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Daromun in Skin Cancer: Clinical Trial page.

Latest updates to the Intratumoral Daromun in Skin Cancer: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history now shows a new revision entry v3.3.3, and the HHS Vulnerability Disclosure link and revision v3.3.2 were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision history updated to include Revision v3.3.2 and remove Revision v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history shows a new revision entry v3.3.1 added and the previous revision v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page no longer displays the notice about government funding delays and operating status that was previously shown at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedRecord History now includes updates for the last known status and recruitment status of NCT04362722, with Philogen S.p.A. listed as sponsor.SummaryDifference1%

- Check90 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice clarifying accessibility and response limitations.SummaryDifference13%

Stay in the know with updates to Intratumoral Daromun in Skin Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Daromun in Skin Cancer: Clinical Trial page.